Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Biopolymers|January 1, 1990
Random coil scission rates determined by time-dependent total intensity light scattering: hyaluronate depolymerization by hyaluronidaseW F Reed, C E Reed, L D Byers
Biopolymers|July 27, 2001
Real-time monitoring of enzymatic hydrolysis of galactomannansJ L Ganter, J C Sabbi, W F Reed
American Journal of Hematology|October 28, 1999
The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study GroupE P Vichinsky, L D Neumayr, C Haberkern, et al.
Blood|March 15, 1996
Phospholipase A2 levels in acute chest syndrome of sickle cell diseaseL A Styles, C G Schalkwijk, A J Aarsman, et al.
British Journal of Haematology|December 21, 2000
Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell diseaseC R Morris, F A Kuypers, S Larkin, et al.
The American Journal of Pediatric Hematology/Oncology|February 1, 1994
Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disordersS P Perrine, N F Olivieri, D V Faller, et al.
Transfusion|September 12, 2001
Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trialE P Vichinsky, N L Luban, E Wright, et al.
Radiology|December 1, 1994
Chronic pulmonary disorders in sickle cell disease: findings at thin-section CTS L Aquino, G Gamsu, J V Fahy, et al.
Blood|May 23, 2001
Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal conjunctival vessel velocity, measured by computer-assisted intravital microscopy, in sickle cell diseaseA T Cheung, P Harmatz, T Wun, et al.
Pediatric Blood & Cancer|October 24, 2009
Hemoglobin Hakkari: an autosomal dominant form of beta thalassemia with inclusion bodies arising from de novo mutation in exon 2 of beta globin geneB Kanathezhath, F K Hazard, H Guo, et al.
Pageof 6